Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EIF2AK2 |
| Upstream (Parents) |
|---|
| (<<) BCAR1 → EIF2AK2 |
| (<<) CASP9 → EIF2AK2 |
| (<<) CDC42EP2 → EIF2AK2 |
| (<<) DHX9 → EIF2AK2 |
| (<<) ELF2 → EIF2AK2 |
| (<<) ELFN1 → EIF2AK2 |
| (<<) GPR153 → EIF2AK2 |
| (<<) GRIN1 → EIF2AK2 |
| (<<) IFITM3 → EIF2AK2 |
| (<<) MAP3K2 → EIF2AK2 |
| (<<) MAP3K7 → EIF2AK2 |
| (<<) MAT2A → EIF2AK2 |
| (<<) MCL1 → EIF2AK2 |
| (<<) MTAP → EIF2AK2 |
| (<<) NBL1 → EIF2AK2 |
| (<<) NDST1 → EIF2AK2 |
| (<<) PIK3R2 → EIF2AK2 |
| (<<) PRPF4B → EIF2AK2 |
| (<<) PTEN → EIF2AK2 |
| (<<) SLC20A1 → EIF2AK2 |
| (<<) SPATA2L → EIF2AK2 |
| (<<) STAT1 → EIF2AK2 |
| (<<) STK40 → EIF2AK2 |
| (<<) TXNIP → EIF2AK2 |
| (<<) ZNF467 → EIF2AK2 |
| Downstream (Children) |
|---|
| EIF2AK2 → ADAM8 (>>) |
| EIF2AK2 → ANKRD37 (>>) |
| EIF2AK2 → CASP2 (>>) |
| EIF2AK2 → CSNK1E (>>) |
| EIF2AK2 → DUSP7 (>>) |
| EIF2AK2 → EPHB4 (>>) |
| EIF2AK2 → HDAC3 (>>) |
| EIF2AK2 → HDAC9 (>>) |
| EIF2AK2 → IRX2 (>>) |
| EIF2AK2 → KISS1R (>>) |
| EIF2AK2 → LRP3 (>>) |
| EIF2AK2 → MEGF6 (>>) |
| EIF2AK2 → PAK2 (>>) |
| EIF2AK2 → RAB15 (>>) |
| EIF2AK2 → RARA (>>) |
| EIF2AK2 → RASSF1 (>>) |
| EIF2AK2 → RPS14 (>>) |
| EIF2AK2 → SLMO2 (>>) |
| EIF2AK2 → SMOX (>>) |
| EIF2AK2 → SUFU (>>) |
| EIF2AK2 → SUMF1 (>>) |
| EIF2AK2 → TGFA (>>) |
| EIF2AK2 → YWHAG (>>) |
